Related Experiment Video
Updated: Jun 17, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Antifungal stewardship in the UK: where are we now?
Silke Schelenz1, Samir Agrawal2,3, Aaron Brady4,5
1School of Immunology & Microbial Sciences, Kings College London, London, UK.
Background:
Antifungal stewardship (AFS) is the judicious use of today's antifungal agents with the aim of improving patient outcomes and preserving their future effectiveness. Antifungal resistance (AFR) is increasing globally, with more patients at risk of Invasive Fungal Disease (IFD), highlighting the urgent need to standardize AFS practices in the UK. The aim of this position paper is to understand the current AFS landscape in the UK.
Methods:
A virtual panel discussion was held from September to October 2023 on an online platform followed by a virtual meeting with nine healthcare professionals from across the UK selected for their expertise on IFD management and AFS. The discussion was structured across four topics: current AFS landscape, key elements of an AFS programme, diagnostics and diagnostic stewardship, and unmet needs in education and training. A thematic analysis was carried out. The results represent the collated and summarized views from these activities.
Results And Discussion:
Participants reported barriers to implementing AFS and its integration within antimicrobial stewardship (AMS) programmes in the UK. The primary challenge identified was a lack of resources, including funding and staff time. Sub-optimal fungal diagnostics and limited mycology expertise was reported as a barrier to AFS, clinical IFD and AFR surveillance. Approaches to combatting these challenges may include investing in formal mycology networks to serve as centres of clinical expertise and diagnostic hubs.
Conclusion:
National standards for AFS services and associated outcome metrics need to be established to set a benchmark for centres to improve AFS.
Insights
Antifungal stewardship (AFS) in the UK faces challenges due to limited resources and diagnostic expertise. Establishing national standards is crucial for improving patient outcomes and combating antifungal resistance (AFR).
Area of Science:
- Medical Mycology
- Infectious Diseases
- Antimicrobial Stewardship
Background:
- Rising global antifungal resistance (AFR) necessitates improved Invasive Fungal Disease (IFD) management.
- Antifungal stewardship (AFS) is vital for optimizing antifungal agent use and preserving efficacy.
- Standardizing AFS practices in the UK is an urgent priority.
Purpose of the Study:
- To assess the current landscape of Antifungal Stewardship (AFS) in the United Kingdom.
- To identify key challenges and opportunities for AFS implementation and integration within Antimicrobial Stewardship (AMS) programmes.
Main Methods:
- A virtual panel discussion and meeting were conducted with nine UK-based IFD and AFS experts.
- Discussions covered the current AFS landscape, programme elements, diagnostics, and training needs.
- Thematic analysis was used to summarize expert views.
Main Results:
- Key barriers to AFS implementation include lack of funding and staff time.
- Sub-optimal fungal diagnostics and limited mycology expertise hinder AFS and surveillance efforts.
- Developing formal mycology networks is proposed to enhance expertise and diagnostics.
Conclusions:
- National standards and outcome metrics for AFS services are needed.
- Establishing benchmarks will drive improvements in AFS across UK centres.
- Addressing resource and expertise gaps is critical for effective AFS.
Related Concept Videos
Hand hygiene
Hand washing...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Antimicrobial Effectiveness
Cryptococcal Meningitis
Candidiasis
Antifungal Agents

